A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
Clinical trial NCT06998524 · RECRUITING
Trial details
- NCT number
- NCT06998524
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-27
- Primary completion
- 2027-04-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.